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ABSTRACT 
Ceramide, sphingomyelin, and glycosphingolipids (both neutral and acidic) are 
characterized by the presence in the lipid moiety of an aliphatic base known as 
sphingosine. Altogether, they are sphingolipids particularly abundant in neuronal plasma 
membranes, where, via interactions with the other membrane lipids and membrane 
proteins, they play a specific role in modulating the cell signalling processes. The 
metabolic pathways determining the plasma membrane sphingolipid composition are thus 
the key point for functional changes of the cell properties. Unnatural changes of the 
neuronal properties are observed in sphingolipidoses, lysosomal storage diseases 
occurring when a lysosomal sphingolipid hydrolase is not working, leading to the 
accumulation of the substrate and to its distribution to all the cell membranes interacting 
with lysosomes. Moreover, secondary accumulation of sphingolipids is a common trait of 
other lysosomal storage diseases. 
In this review article, we report on the sphingolipid chemical and biochemical properties 
and discuss some hypotheses about the possible links between sphingolipid incorrect 
catabolism and neurodegeneration. 
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INTRODUCTION 
Sphingolipids are amphiphilic membrane lipids characterized by the presence of 
sphingosine, an amino-and-hydroxy alkylic long chain. After more than a century of 
studies, we now know their structure, their physico-chemical properties, their distribution 
and content in cells and tissues of many animal species, including humans (Sonnino et al. 
2006). The final cellular site for sphingolipids is the plasma membrane, however their 
complex metabolic pathway requires many intracellular processes, so that a not negligible 
portion of them is also found intracellularly (Schulze et al. 2009, Kolter & Sandhoff 2010, 
Sandhoff & Kolter 2003, Hannun & Obeid 2018). As amphiphilic compounds they contain a 
hydrophilic head group, for example a saccharide, an oligosaccharide, a phosphocholine, 
protruding into the cell aqueous environment, and a hydrophobic chain called ceramide, in 
which the sphingosine is linked with a fatty acid via an amidic bond, inserted into the outer 
layer of plasma membrane. 
 
Sphingolipids are typically asymmetric components of the plasma membranes enriched in 
the outer leaflet (van Meer 2011, van Meer & Hoetzl 2010, Fujimoto & Parmryd 2016), 
however it cannot be excluded that a minor pool of them could be transiently inserted into 
the inner layer with the hydrophilic group facing the cytosol. The hydrophilic group, thanks 
to the presence of carbohydrates and/or ionic charges, attracts water and ions, forms 
hydrogen bonds and easily interacts with the group of membrane components protruding 
from the membrane itself. At the water-lipid interface, the sphingolipid ceramide amide 
linkage accepts hydrogen bonds on the carbonyl group and donates hydrogen bonds via 
the N-H group, allowing the formation of a double linkage, which works as a padlock within 
molecules. The lipid moiety inserted into the lipid layer interacts with the lipid portion of the 
cholesterol in the membrane and with dipalmitoylphosphocholine, leading to the formation 
of membrane domains with reduced fluidity, now worldwide known as lipid rafts (Sonnino 
et al. 2006, Sonnino & Prinetti 2013, Sonnino et al. 2007). Most of the available 
information on the composition and organization of lipid rafts relies on the preparation and 
analysis of low-density, detergent-resistant membrane (DRM) fractions from cells, tissues 
or even entire organisms. The notion that lipid-driven segregation of membrane 
components could be a major mechanism for the creation of lateral order in biological 
membranes was supported by at least a decade of studies on model membranes, before 
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the formulation of the “lipid raft hypothesis” (van Meer et al. 1987). However, the method 
published by Brown and Rose describing the isolation of a putative lipid raft fraction based 
on its resistance to solubilization by Triton X-100 under well defined experimental 
conditions (Brown & Rose 1992) has hallmarked an explosion of investigations using this 
method to study the biological roles of lipid rafts. DRM are highly enriched in sphingolipids 
and cholesterol, and relatively void of bulky membrane glycerolipids (for a detailed 
analysis of the lipid composition of DRM prepared from primary cultured neurons, see 
(Prinetti et al. 2001)). The method, despite its enormous popularity, has elicited as well 
fierce opposition, based on some pieces of evidence indicating that the fraction prepared 
with this method might be artifactual and not reflecting the real lipid raft structure as it 
occurs in living cells (for a detailed discussion about this issue, see our reviews (Sonnino 
& Prinetti 2008, Sonnino & Prinetti 2013)). The evolution of different technologies enabling 
to probe the heterogeneous organization of cellular membranes suggested that 
“membrane domains” (among those, lipid-driven domains or “lipid rafts”) are a multiple, 
heterogeneous, highly dynamic ntities, part of a complex organization hierarchy 
(Bernardino de la Serna et al. 2016, Lu & Fairn 2018, Sezgin et al. 2017, Santos & Preta 
2018). Isolated DRM fractions capture a non-dynamic situation representing the average 
or sum of different situations. In this sense, D M are indeed an artifact (as almost any kind 
of biochemical preparation, defining an experimental item that is not reflecting the complex 
reality of the in vivo counterpart). On the other hand, a few diverse techniques enabling to 
observe organized domains in intact cell membranes (immune-electron microscopy under 
conditions respecting the lipid integrity of the membrane (Fujita et al. 2007), stimulated 
emission depletion nanoscopy (Iwabuchi et al. 2012, Eggeling et al. 2009) and 
fluorescence correlation spectroscopy (Sezgin et al. 2012)) have demonstrated the 
clustering and confinement of different glycosphingolipids at the plasma membrane level. 
 
Sphingolipids are ubiquitous components of mammal cell membranes, which are 
particularly abundant in the nervous system, and, within the nervous system, in neurons 
(Hansson et al. 1977, Schnaar 2016). Thus, sphingolipids are relatively abundant 
components of the outer layer of neuronal plasma membranes making their concentration 
very high in neuronal lipid rafts (Prinetti et al. 2001). Remarkably, membrane segregation 
of sphingolipids in neurons seems to be higher than in any other cell type investigated so 
far. Lipid rafts contain a few proteins, involved in cell signaling processes, whose 
functional features are modulated through direct specific glycosphingolipid-protein 
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interactions or through a sphingolipid-dependent dynamic membrane organization (Prinetti 
et al. 2009). As a matter of fact, several experimental approaches, which eventually lead to 
alterations in the organization of the plasma membrane due to changes in sphingolipid 
content or pattern, have been proven to be very effective in modulating cell functions.  
 
METABOLISM OF SPHINGOLIPIDS 
The sphingolipid metabolism combines several metabolic pathways, correlated with each 
other and aimed at obtaining and maintaining a defined cell- and stage-specific cellular 
content and plasma membrane pattern (Sandhoff & Kolter 2003, Yu et al. 2009, Furukawa 
et al. 2014). Figure 2 shows a schematic representation of the complex sphingolipid 
metabolic pathway. 
Differentiated neurons display the more complex sphingolipid pattern within all mammalian 
cells (Svennerholm et al. 1994). In these neurons, sphingomyelin is the most abundant 
sphingolipid. Gangliosides are distributed, all in similar quantity, among mono-, di-, tri- and 
tetra-sialo compounds of the ganglio-4, Gg4, series. The sphingolipid pattern changes 
during the differentiation of the nervous system and parallels the expression of the 
sphingolipid synthases (Yu et al. 2009, Prinetti et al. 2001, Riboni et al. 1990). 
Sphingolipids are present in low amounts in the first stages of differentiation, then their 
levels increase progressively as the differentiation process proceeds, before reaching a 
phase of the process where they remain constant for many years. This phase is then 
followed by a decrease in the sphingolipid content in very aged people. During the stages 
of neural tube formation and neural stem cells proliferation, the ganglioside pattern is 
characterized by the mono- and disialogangliosides of the Lac series, GM3 and GD3. 
Then, these gangliosides become very scarce, giving way to the more complex 
gangliosides of the Gg4 series (GM1, GD1a, GT1b and GQ1b) as neurogenesis and 
astrocytogenesis proceed. These gangliosides reach their highest quantity with 
synaptogenesis and axonal/dendritic arborization (Schnaar 2016). At the onset of terminal 
differentiation, synthesis of galactosylceramide and sulfatide in the brain is switched on, 
then remains constant in mature oligodendrocytes (Norton & Poduslo 1973). 
Sphingomyelin is also very scarce at the beginning of differentiation growing then 
hyperbolically and reaching the maximum level in fully differentiated cells. In differentiated 
rat cerebellar granule neurons, sphingomyelin content is 1.00 nmol/106 cells, while 
gangliosides account for 0.79 nmol/106 cells, with a total glycerophospholipid content of 
32.84 nmol/106 cells (Prinetti et al. 2001). 
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The sphingolipid content is strictly related to the synthesis and content of sphinganine, 
which displays a C18/C20 sphinganine ratio progressively reduced along differentiation. 
The C20 species can hardly be detected in the first stages of differentiation. This is due to 
a different activity of the palmitoyl- and stearoylCoA acyl–serine transferases along 
neuronal differentiation (Chigorno et al. 1997), which results in the slow but continuous 
increase in the content of gangliosides that contain C20-sphingosine during neuronal 
maturation and aging (Valsecchi et al. 1993, Sonnino & Chigorno 2000). 
 
De novo biosynthesis of sphingolipids starts with the synthesis of ceramide in the 
endoplasmic reticulum and proceeds in the Golgi apparatus (see reference (Hannun & 
Obeid 2018) for details). Neobiosynthesized sphingolipids reach the plasma membranes 
via vesicular transport, becoming thus components of the external leaflet (Sandhoff & 
Kolter 2003, van Meer & Hoetzl 2010).  
Ceramide follows two paths to reach the Golgi, via the soluble transporter protein CERT to 
become sphingomyelin in the luminal site, and via vesicle transport to become 
glucosylceramide by glucosyltransferase on the cytosolic side of the membrane (van Meer 
& Lisman 2002). Glucosylceramide can be translocated to the luminal side of the Golgi 
membrane becoming substrate for the lactosylceramide synthases (D'Angelo et al. 2007). 
A part of glucosylceramide is directly transported by a specific protein from the membrane 
cytosolic layer of Golgi to the plasma membrane inner layer and to the outer by a flippase 
(Warnock et al. 1994).  
 
On the other hand, the biosynthetic activity at Golgi level is not the only event influencing 
the final sphingolipid pattern associated with the plasma membrane. Indeed, the plasma 
membrane itself is an active site for metabolic remodeling of the local sphingolipids. Both 
hydrolytic and biosynthetic sphingolipid enzymes, associated to the plasma membranes, 
have cis and trans activities (Preti et al. 1980, Saito et al. 1995, Aureli et al. 2014a, Aureli 
et al. 2014b, Aureli et al. 2012, Aureli et al. 2011, Sonnino et al. 2010). Plasma membrane-
associated sphingomyelinases, sialidases, hexosamindase, galactosidase, glucosidases, 
sphingomyelin synthase, sialyltransferase have been characterized and studied (see 
references (Schnaar 2016, Hannun & Obeid 2018) for details). Hydrolysis of SM by PM-
associated acid or neutral SMases, and synthesis of SM from ceramide by SMS2 likely 
play an important role in regulating the formation, at the plasma membrane, of ceramide-
enriched domains acting as signaling platforms (Zhang et al. 2009) or initiating vesiculation 
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processes (Holopainen et al. 2000). Regulation of PM ceramide levels, or more complex 
modulation of glycosphingolipid patterns and glycosphingolipid-dependent signaling can 
also be achieved through the action of PM-associated glycohydrolases or 
glycosyltransferases (Sonnino et al. 2010). Hydrolase activities are likely modulated by the 
activity of proton pumps able to determine local acidification in proximity of the lipid raft 
microenvironment, to obtain optimum acidic pH required for the enzyme activity (Aureli et 
al. 2012).  
Glycosylation/deglycosylation is not the only opportunity for the local modulation of PM 
glycosphingolipid composition. The local increase in proton concentration in proximity of 
glycosphingolipid-enriched membrane domains determined by the activity of the proton 
pumps/antiporters mentioned above favors the formation of ganglioside lactones, in 
particular GD1b lactones. The lactonization process deeply influences the conformational, 
aggregational and biological properties of gangliosides (Acquotti et al. 1987, Bassi et al. 
1991), even if its biological relevance is still poorly understood. However, in human brain 
the content of GD1b-lactone, that is very small in young subjects, significantly increases 
with the aging process (Riboni et al. 1986). 
A further opportunity for the remodeling of the PM sphingolipid pattern is represented by 
the release of sphingolipids or sphingolipid-rich vesicles from the plasma membrane into 
the extracellular environment (at least, in cultured cells (Chigorno et al. 2006)). On the 
other hand, sphingolipids present in the extracellular milieu are taken up, at least partially, 
by cells (not necessarily by the same cells from which they have been released), 
remaining associated with the cell membranes.  
 
While the enzymology of sphingolipid de novo biosynthesis and remodeling at the PM level 
has been unveiled in many of its details, still relatively little is known about its regulation, 
even if the regulation of the biosynthetic pathway has been regarded for a long time as the 
main mechanism responsible for the formation of a cell- and stage-specific sphingolipid 
pattern.  
Sphingolipid synthesis is mainly regulated at the transcriptional level through the control of 
the expression levels of ceramide synthases, sphingomyelin synthases, 
glycosyltransferases or transporter proteins. Indeed, the changes in cellular 
glycosphingolipid patterns occurring in neurons along neurogenesis, axonal arborisation 
and synaptogenesis, as well as in oligodendrocytes along differentiation and myelin 
formation, are nicely paralleled by changes in the expression of the corresponding 
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glycosyltransferases (Ngamukote et al. 2007, Yu et al. 2009), and apparently histone 
acetylation of the glycosyltransferase genes represent an important regulatory in brain 
(Suzuki et al. 2011, Itokazu et al. 2017). An important regulation mechanism for the 
reaction catalyzed by the serine-palmitoylCoA transferase, which likely represents the 
rate-limiting step in the biosynthetic pathway, is represented by an inhibitory feedback 
controlled in mammals by ORMDL proteins (Gupta et al. 2015, Siow & Wattenberg 2012). 
In addition, it has been recently suggested that ceramide synthase activity could be 
relevantly regulated at the protein level by phosphorylation (Wegner et al. 2016).  
However, the possibility that differential intracellular flows of different sphingolipids could 
influence the resulting sphingolipid patterns (independently from the expression levels of 
synthases) should not be neglected. In other words, the regulation of intracellular 
sphingolipid traffic might be of equal importance as the control of synthetic enzymes 
expression in determining the final sphingolipid composition of the plasma membrane. 
From this point of view, it is worth to recall that the mechanism of glucosylceramide 
delivery to the ganglioside biosynth tic machinery in the Golgi is likely not mediated by the 
transport protein FAPP2. It is generally assumed to be due to a vesicular transport, 
however this crucial point in the biosynthetic pathway of gangliosides remains elusive. 
 
The degradation of plasma membrane sphingolipids takes place in the lysosomes, that are 
reached by the endocytic vesicular flow through the early and late endosomal 
compartment (Kolter & Sandhoff 2005). Along their route to the lysosomes, the plasma 
membrane sphingolipids can be diverted to the Golgi apparatus where they undergo direct 
glycosylation with the formation of more complex products, able in turn to reach again the 
plasma membrane. It has been suggested that this process might be quantitatively 
relevant at least for certain cell types, including neurons (Riboni et al. 1994), thus 
representing potential mechanism for the regulation of plasma membrane sphingolipid 
pattern at the level of intracellular traffic.  
After reaching reached the lysosomes, sphingolipids are catabolized to simple compounds 
(Kolter & Sandhoff 2005, Kolter & Sandhoff 2010), but some glycolipid intermediates 
escape from the lysosomes and can reach directly the Golgi entering into the biosynthetic 
pathway. This salvage pathways, related to gangliosides, in neurons are not negligible 
from the quantitative point of view (Riboni et al. 1996), but very little is known about the 
mechanisms of escape from the lysosome and the transfer of these intermediates to the 
Golgi or other cellular districts, nor on the regulation of these processes. The presence of 
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soluble ganglioside-protein complexes in the cytosol might reflect, at least in part, the 
intracellular traffic linked to the recycle of these intermediates (Sonnino et al. 1979). On 
the other hand, it is well known that lysosomes interact with many cellular organelles and 
with the plasma membrane. Processes of membrane fusions could be responsible for the 
shift of glycolipids from one cellular compartment to another (for details, see the following 
section). 
 
The final degradation products, sphingosine, fatty acids and sugars, leave the lysosomes 
through specific membrane proteins and, in part, are recycled for the biosynthesis of new 
sphingolipids (Sonderfeld et al. 1985, Tettamanti 2004, Riboni et al. 1996). In particular, 
the recycling of sphingosine is very high and in some cells covers up to 80% the need of 
the long chain base for sphingolipid biosynthesis (Riboni et al. 1999). However, 
information on the intracellular trafficking of sphingosine, from lysosomes to the reticulum 
is not available. Lysosome-originated sialic acid is also recycled at a great extent for the 
biosynthesis of sialoglycoconjugates. Sialic acid escape from the lysosomes requires the 
membrane protein sialin (Prolo et al. 2009). The lack of sialin leads to lysosomal 
impairment and neurodegeneration in the pathology known as Salla’s disease. 
Sphingolipid lysosomal catabolism is not a simple process (Kolter & Sandhoff 2006, Kolter 
& Sandhoff 2010). Sphingolipids are components of the external layer of plasma 
membranes and upon membrane endocytosis they become components of the negatively 
curved luminal layer of the limiting lysosomal membrane, which is covered by a thick and 
complex glycocalix (Eskelinen et al. 2003). Thus, their accessibility to the lysosomal 
hydrolytic enzymes and activator proteins would be limited, resulting in a slow and difficult 
hydrolytic process. Small endo-lysosomal vesicles characterized by a high content of 
bis(monoacylglycero)phosphate, with the sphingolipids in the outer layer facing the lysosol 
with a topology more suitable to the enzymatic hydrolysis, are rapidly formed in the late 
lysosomes (Schwarzmann et al. 2015). Thus, both lysosomal membrane sphingolipids and 
endo-lysosomal vesicle membrane sphingolipids can be found in the lysosomes. The 
implications of lysosome fusion with the PM will be discussed in the next section.  
 
According to this scenario, it is clear that the sphingolipid plasma membrane composition 
can be easily modified by different metabolic mechanisms. This is very relevant from the 
functional point of view, considering the ability of sphingolipids to modulate the biological 
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functions of PM-associated proteins, the membrane lateral organization (Prinetti et al. 
2009).  
However, the processes of neobiosynthesis and subsequent transport to the plasma 
membrane of the final compounds seem to require too much time to be used to modify the 
plasma membrane sphingolipid concentration and pattern in response to intra- and 
extracellular signals. In addition, it has been reported that the glycosphingolipid half life is 
short in neurons (Riboni et al. 1990, Prinetti et al. 2000). On the other hand, as discussed 
above, changes of sphingolipid pattern could be rapidly achieved upon activation of 
plasma membrane-associated enzymes as a consequence of ligand-triggered interactions, 
changes in their membrane lipid microenvironment or local proton concentration. 
Nevertheless, great care must be devoted also to the intracellular sphingolipid trafficking 
and to the recycling of partially degraded sphingolipids, which implies an important role of 
lysosomal activity. 
Any derailment from the correct metabolic/traffic process can lead to an abnormal 
sphingolipid composition of the plasma membrane and, consequently, to an abnormal cell 
function modulation. 
 
SPHINGOLIPIDS AND LYSOSOMAL STORAGE DISORDERS (LSDs).  
Lysosomal storage disorders are a wide group of genetic diseases due to reduced or 
absent enzymatic activity of catabolic lysosomal enzymes.  
Altogether, more than 70 different LSDs are known, with an incidence of 1:200,000 - 1: 
350,000 each. This makes the overall LSDs incidence around 1:5,000. Within LSDs, we 
count several sphingolipidoses due to genetic anomalies related to either the sphingolipid 
hydrolytic enzyme or the activator protein necessary for the enzyme activity. 
Glycohydrolases are exo-enzymes, and the incorrect catabolic process leads to the 
cellular primary accumulation of the enzyme substrate followed by a secondary 
accumulation of compounds likely due to lysosomal impairment (Fuller & Futerman 2018). 
In fact, secondary cell sphingolipid accumulation occurs probably in any cell with badly 
working lysosomes (see Table 1). 
The main site of intracellular degradation of plasma membrane SL is represented by intra-
endolysosomal vesicles (LVs) inside the late endosomal and lysosomal compartment, 
which are formed by an inward budding of the limiting endosomal membrane. Indirect 
evidence suggests that SL are sorted from the limiting lysosomal membrane to the intra-
endolysosomal membranes: in fact, gangliosides artificially incorporated into the limiting 
lysosomal membrane are protected from degradation, while on the other hand they are 
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promptly degraded at the lysosomal level upon normal plasma membrane turnover by 
endocytosis (Henning & Stoffel 1973). However, it is not known whether a certain amount 
of SL, after reaching the lysosome, remain associated with the limiting lysosomal 
membrane, thus escaping degradation. In rat liver, GM1 and GD1a can be formed by 
direct glycosylation of intravenously administered GM2 (Trinchera & Ghidoni 1990). In 
cultured neuroblastoma cells and neurons, exogenously administered GM1 can be 
converted into GD1a and GD1a into GT1b in the presence of chloroquine (Tettamanti 
2004). These findings strongly suggest that a significant pool of ganglioside can escape 
lysosomal degradation and reach the Golgi apparatus, possibly by avoiding the sorting to 
degradation-prone LVs and remaining confined to the limiting lysosomal membrane. It is 
reasonable to expect that the magnitude of this pool might increase when for any reason 
sphingolipids are accumulated at the lysosomal level. An indirect support to this 
hypothesis comes from the finding that SM levels at the plasma membrane (as judged by 
lysenin staining) are 3.8 fold higher in cultured hippocampal ASM knock-out vs. wild type 
mice (Ledesma et al. 2011, Galvan t al. 2008). 
The complexity of LSD, at the phenotypic and molecular level, particularly considering the 
aspects related to neuronal dysfunctions, clearly indicates that lysosomal impairment by 
itself might not necessarily be the central event in the pathogenesis of these diseases. 
Considering the importance of sphingolipid-dependent signal transduction and of 
sphingolipid-driven membrane organization (Santos & Preta 2018) in the physiology of 
neural cells, the obvious question is if and how primary or secondary accumulation of 
undegraded sphingolipids at the endosomal/lysosomal level could affect the 
composition/organization of the plasma membrane and of intracellular membranes limiting 
different organelles, with consequences on the pathology at the level of the nervous 
system.  
Endosome/lysosomes can fuse with the plasma membrane. The exocytosis of 
multivesicular endosomes is likely the main mechanism leading to the release of 
exosomes, and has been extensively studied under this perspective (Harding et al. 2013), 
while the contribution of this event to a possible remodeling of the PM composition has 
received much less attention. On the other hand, it has been shown that lysosomes can 
fuse with the PM in response to the increase in intracellular Ca2+, behaving as ubiquitous 
Ca2+-regulated secretory vesicles (Rodriguez et al. 1997). Ca2+-regulated exocytosis of 
lysosomes has been proposed as a mechanism for restoring the PM integrity after injury 
(Reddy et al. 2001) or for the insertion of pore-forming proteins such as certain bacterial 
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toxins (Andrews et al. 2014). This process has been shown in several cellular models; 
however its relevance in vivo is still not confirmed, since only a few studies in tissues are 
available (Cheng et al. 2015, Jimenez & Perez 2017, Krause et al. 1994). The Ca2+-
sensing lysosomal protein synaptotagmin VII seems the crucial player for the regulation of 
the fusion of lysosomes with the PM upon influx of extracellular Ca2+ as a consequence of 
the loss of PM integrity (Reddy et al. 2001). In addition, PM repair by lysosomal fusion 
requires the rapid mobilization of lysosomes from the perinuclear region to the proximity of 
PM along microtubules via kinesin motors, or the transport of lysosomes, already present 
in the proximity of the PM, to the PM itself via actin filaments, events regulated by small 
GTPases, including Rab3a (Encarnocao et al. 2016) and Arl8b (Michelet et al. 2018). The 
exact mechanism by which lysosomal exocytosis promotes PM repair is still not clearly 
understood. The fusion could give origin to an intracellular “membrane patch” which could 
directly fuse with the wounded membrane leading to PM resealing. However, it is quite 
difficult to imagine a direct merge of the intracellular patch with the irregular wound. An 
alternative explanation could be the spontaneous resealing of the bilayer due to the 
reduction in membrane tension consequent to the exocytic process. A third, more complex 
possibility implies the enzymatic remodeling of the PM lipid composition as a consequence 
of the lysosomal fusion (reviewed in (Andrews et al. 2014)). Lysosomal acid 
sphingomyelinase (ASM) is secreted in the extracellular space or translocated to the cell 
surface upon membrane-damaging conditions. The hydrolytic activity of ASM on SM 
present in the outer leaflet of the PM can lead to the production of ceramide and of 
ceramide-enriched microdomains, triggering membrane dynamic remodeling and 
membrane invagination with consequent endocytosis, which in turn contributes to the 
removal of the lesion PM area. Lesion removal by ASM-regulated endocytosis would 
explain why Ca2+-dependent lysosomal exocytosis, also repairs PM lesions caused by the 
insertion of pore-forming proteins. Besides ASM, other lysosomal hydrolytic enzymes 
acting on glycosphingolipids (β-hexosaminidases, sialidases, β-galactosidases, β-
glucocerebrosidases) (Aureli et al. 2014a) can reach the PM after lysosomal exocytosis, 
potentially leading to the local production of ceramide or to a remodeling of the 
glycosphingolipid pattern of lipid raft/caveolar membrane domains. Indeed, glycolipid 
remodeling in caveolar domains could play a relevant role in this scenario, since caveolar 
endocytosis significantly contributes to PM lesion removal, as demonstrated by the 
observation that depletion of caveolin-1 by siRNA inhibited PM repair (Corrotte et al. 
2013). 
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All these proposed mechanisms imply the traffic of lysosomal components (lipids and 
enzymes associated with the limiting lysosomal membrane or soluble material present in 
the lysosomal lumen) to the cell surface. When considering the situation of LSD, this has 
profound implications that could explain the diversity of PM-generated alterations observed 
in these diseases (such as, merely as example, the ectopic dendritogenesis reported in 
GM2 gangliosidoses (Purpura & Suzuki 1976), as well as in α-mannosidosis (Siegel & 
Walkley 1994) and MPS type I (Walkley 2003), where secondary storage of GM2 is 
present). Most genes involved in lysosomal biogenesis and in lysosomal functions 
(including autophagy and lysosomal exocytosis) are under the control of the transcription 
factor EB (TFEB). The aberrant storage of uncatabolized material, common to all LSDs, 
induces the dephosphorylation of TFEB and its translocation to the nucleus, with the 
consequent activation of its target genes, leading to increased lysosomal biogenesis (a 
possible compensatory mechanism for the loss of lysosome functionality) (Sardiello et al. 
2009). TFEB overexpression was sufficient to activate several key lysosomal genes and to 
induce lysosomal biogenesis. TFEB pathway was activated upon lysosomal storage of 
sucrose, a useful experimental model of lysosomal impairment, and TFEB activation was 
demonstrated in fibroblasts from mouse models of three different LSDs, 
Mucopolysaccharidoses types II (Muenzer et al. 2002) and IIIA (Hemsley & Hopwood 
2005) (MPSII and MPSIIIA) and Multiple Sulfatase Deficiency (Settembre et al. 2007) 
(MSD). In addition, increased lysosomal biogenesis (even if not necessarily linked only to 
TFEB activation) was shown in several others LSDs or in their animal models 
(summarized in Table 2). Our group recently showed that, in sucrose-loaded human 
fibroblasts, reduced lysosomal activity led to the accumulation of undegraded sphingolipids 
both intracellularly and at the PM level, with consequent arrest of cell proliferation. 
Remarkably, this was accompanied by increased lysosomal biogenesis and lysosome 
fusion with the PM (Samarani et al. 2018). Obviously, increased lysosomal biogenesis in 
principle favors the traffic of lysosomal components to the cell surface with the above-
described mechanisms implying lysosomal fusion with the membrane. This would explain 
the contribution of PM alterations to the pathogenesis of LSDs. 
In addition to lysosome-mediated vesicular transport of lipids and lipid-specific enzymes, 
another form of lipid traffic has received much attention in recent times, and could 
contribute to alterations of lipid composition outside the lysosome in LSD, involving not 
only the PM but also intracellular membranes. It is becoming evident that intracellular 
organelles are physically and functionally interconnected by a complex network of contact 
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sites between the membranes of different organelles (Membrane Contact Sites, MCSs) 
(reviewed in (Helle et al. 2013)). The endoplasmic reticulum (ER) establishes MCSs with 
almost all other cellular membranes, including the PM, lysosomes, early endosomes, 
endolysosomes and autophagic vacuoles, even if the best studied MCS is represented by 
the mitochondria-associated ER membranes (MAMs). 
In additions, MCSs have been detected between lysosomes and mitochondria, lysosomes 
and the nuclear envelope, mitochondria and the Golgi membranes. The molecular 
organization of MCSs is complex and not fully understood, however it requires the 
tethering of both membrane protein complexes and lipids (likely organized as specialized 
lipid rafts) allowing to maintain the juxtaposed membranes in strict contact without 
undergoing fusion.   Even if fusion does not occur, active exchange of lipids seems to take 
place, and one of the main supposed functions of MCSs seems the interorganelle lipid 
exchange. Since mitochondria are disconnected from vesicular traffic, exchange of lipids 
between ER and mitochondria at MAMs is likely crucial for the correct shaping of 
mitochondrial phospholipid pattern. Likely, lipid transport at MCSs involves lipid transport 
proteins able to extract lipids from a membrane and deliver it to the adjacent one. In the 
case of sphingolipids, at least two of such proteins, CERT (Kudo et al. 2008) and CLN8 
(Winter & Ponting 2002), have been implicated as possible transporters of ceramide and 
other sphingolipids at MCSs. Topology of sphingolipids requires further care and according 
to their localization to one of the two membrane layers, together with the lipid transport 
proteins, flippase could be also necessary, this mak ng the process of their transport at 
MCSs further complex. To date, still little is known about the contribution of altered lipid 
traffic at MCSs in LSDs. The best-studied example is GM1-gangliosidosis (reviewed in 
(Annunziata et al. 2018)). In the β-Gal-/- mice, the animal model of GM1-gangliosidosis, 
GM1 is massively accumulated in brain, and in particular in neurons, which undergo 
significant degeneration and death followed by micro- and astrogliosis. In neurons from β-
Gal-/- mice brain, GM1 accumulation at the lysosomal level is accompanied by its abnormal 
redistribution from the lysosomes and the PM to the ER, where it accumulates prevalently 
at the level of MAMs. Increased GM1 levels in MAMs lipid rafts trigger a complex series of 
events leading to the formation and activation of a mitochondrial Ca2+ pore, and ultimately 
to the activation of the mitochondrial intrinsic apoptotic pathway. Interestingly, it has been 
shown that, on the other hand, changes in the structure of mitochondrial lipid rafts can play 
roles in the protection from neurotoxic stimuli (Garofalo et al. 2018). 
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Taken together, all these pieces of evidence suggest that the hypothesis we proposed, 
that “the blockade of proper SL catabolism at the lysosomal level leads to the jamming of 
the overall flow of metabolites, with consequences on the SL composition in all cellular 
districts” (Piccinini et al. 2010) is still valid, however the “jamming” is likely much more 
complex than we would have expected, and involves highly specific events. Accumulation 
of SL in lysosomes in LSDs, either primary or secondary, eventually leads to a 
redistribution of SL in other subcellular districts. Considering the incredible complexity of 
the brain lipidome, the diversity of biological functions of different SL in different brain cell 
populations, and the variety of mechanisms potentially driving SL from lysosomes to other 
cellular membranes, with consequences of their organization, it is not surprising that 
neurological manifestations encompass a wide spectrum in LSDs. Addressing this 
diversity is one of the challenges of the basic research in this field. 
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Table 1. Primary or secondary accumulation of (glyco)sphingolipids in LSDs ((Ballabio & Gieselmann 2009, Walkley & Vanier 2009, Hulkova et al. 2005, Piccinini et al. 2010) and 
references herein) 
Disease Primary biochemical defect Primary storage material  Secondary GSL storage 
Mucopolysaccharidoses (MPS)    
MPS I (Hurler and related) α-iduronidase dermatan sulphate, heparan sulphate GM2, GM3 
MPS II (Hunter) iduronate-2-sulphatase dermatan sulphate, heparan sulphate GM2, GM3, LacCer  
MPS IIIA (Sanfilippo) heparan-N-sulphatase heparan sulphate GM2, GM3, GD2,   LacCer 
MPS IIIB (Sanfilippo) N-acetyl-β-glucosaminidase heparan sulphate GM2, GM3, GD2 
MPS IIIC (Sanfilippo) acetylCoA: α-glucosamide N-
acetyltransferase 
heparan sulphate GM2, GM3, GD2 
MPS IIID (Sanfilippo) N-acetylglucosamine-6-sulphatase heparan sulphate GM2, GM3, GD2 
MPS VI (Maroteaux-Lamy) arylsulphatase B dermatan sulphate GM2, GM3 
MPS VII (Sly) β-glucuronidase heparan sulphate, dermatan sulphate, 
chondroitin sulphates 
GM2, GM3 
Sphingolipidoses    
Fabry α-galactosidase A Gb4Cer, Gb4-sphingosine  
Gaucher β-glucosidase GlcCer, GM1, GM2, GM3, GD3, Glc-
sphingosine 
 
Globoid cell leukodystrophy (Krabbe) galactocerebroside β-galactosidase GalCer, Gal-sphingosine LacCer, Gb3Cer, Gb4Cer,  
Metachromatic  leukodystrophy arylsulphatase A Sulfatide and other sulfolipids GM2 
Niemann-Pick A and B sphingomyelinase sphingomyelin GM2, GM3,  GlcCer, LacCer,  Gb3Cer, Gb4Cer 
GM1 gangliosidosis β-galactosidase GM1, GA1, lyso-GM1 GlcCer, LacCer, GM2, GM3, GD1a, 
GM2 gangliosidosis (Tay-Sachs) β-hexosaminidase A GM2, GalNAcGD1a, GA2, lyso-GM2  
GM2 gangliosidosis (Sandhoff) β-hexosaminidase A and B GM2, GalNAcGD1a, globoside, GA2, 
lyso-GM2 
 
Salla Membrane carrier mediating the egress of 
sialic acid from lysosomes 
 gangliosides 
Others    
Niemann-Pick C NPC1 and 2 cholesterol LacCer 
α-mannosidosis α-mannosidase mannose-containing oligosaccharides GM2, GM3 
Glycogenosis type II (Pompe) α-glucosidase glycogen LacCer 
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Table 2. LSDs with increased lysosomal biogenesis 
 
LDSs References 
  
MPSI (Ohmi et al. 2003) 
MPSII (Muenzer et al. 2002, Karageorgos et al. 
1997) 
MPSIIIA (Hemsley & Hopwood 2005) 
MPSIIIB (Ohmi et al. 2003) 
MPSVI (Karageorgos et al. 1997) 
MSD (Settembre et al. 2007) 
MLIV (Venugopal et al. 2009) 
Neuronal ceroid lipofuscinosis 3 (Pohl et al. 2007) 
I-cell disease (Kawashima et al. 2007) 
Fabry (Pereira et al. 2014) 
Niemann-Pick A (Gabande-Rodriguez et al. 2014) 
Niemann-Pick C (Kwiatkowska et al. 2014) 
Sialidosis (Wu et al. 2010) 
Salla (Karageorgos et al. 1997) 
Fucosidosis (Kondagari et al. 2015) 
Pompe (Karageorgos et al. 1997) 
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LEGEND TO FIGURES 
 
Figure 1. Comparison of the volume occupied by ceramide and by the hydrophilic head groups of selected 
sphingolipids.  
Minimum energy structure of ceramide, of phosphocholine (head group of sphingomyelin), galactose (head 
group of galactosylceramide, cerebroside), II3Neu5Ac-Gg4 (head group of ganglioside GM1),    
IV3Neu5Ac,II3Neu5Ac2-Gg4   (head group of ganglioside GT1b) and  IV
4GalNAc,IV3Neu5Ac,II3Neu5Ac-Gg4 
(head group of ganglioside GalNAc-GD1a). Oligosaccharide structures are aligned on the first sugar. 
 
Figure 2. Metabolic pathways of sphingolipids. Representation of the main processes determining the 
membrane sphingolipid composition.  
Ceramide is synthesized in the ER, transported to the Golgi where it is converted into SM and 
glycosphingolipids. Sphingolipids reach the plasma membrane by vesicular fusion and in very minor part 
transported by specific soluble proteins. Cell surface local structural changes can occur due to 
lactonization and to the enzymatic remodeling by cell surface associated hydrolases or synthases. 
Shedding of sphingolipids (Chigorno et al. 2005) as well as their uptake by the membranes were described 
(Saqr et al. 1993). The sphingolipid catabolism mainly occurs in lysosomes, from which sphingosine and 
some sugars can escape to be recycled (Ghidoni et al. 1987). Some primary and secondary lysosomes 
fuse with other membranes or exchange their membrane components (Trinchera et al. 1990).   
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In this review article, we report on the 
sphingolipid chemical and biochemical 
properties and discuss some hypotheses 
about the possible links between sphingolipid 
incorrect catabolism and neurodegeneration. 
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